Improving the safety of high-dose methotrexate for children with hematologic cancers in settings without access to MTX levels using extended hydration and additional leucovorin

Preventing and Managing Toxicities of High-Dose Methotrexate

(2016) S. C. Howard et al.   ONCOLOGIST

Serum Creatinine Versus Plasma Methotrexate Levels to Predict Toxicities in Children Receiving High-dose Methotrexate

(2015) Priya Tiwari et al.   PEDIATRIC HEMATOLOGY AND ONCOLOGY

Methotrexate Associated Renal Impairment Is Related to Delayed Elimination of High-Dose Methotrexate

(2015) Shi-Long Yang et al.   TheScientificWorldJOURNAL

Methotrexate Associated Renal Impairment Is Related to Delayed Elimination of High-Dose Methotrexate

(2015) Shi-Long Yang et al.   Scientific World Journal

Serum creatinine and creatinine clearance for predicting plasma methotrexate concentrations after high-dose methotrexate chemotherapy for the treatment for childhood lymphoblastic malignancies

(2013) Wei-qun Xu et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Experience with high dose methotrexate therapy in childhood acute lymphoblastic leukemia in a tertiary care cancer centre of a developing country

(2012) Gauri Kapoor et al.   PEDIATRIC BLOOD & CANCER